AXA S.A. - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
AXA S.A. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q2 2019$11,576,000
+76.4%
249,840
-7.2%
0.02%
-11.5%
Q1 2019$6,564,000
-0.2%
269,252
-41.7%
0.03%
-10.3%
Q4 2018$6,576,000
-6.3%
461,4860.0%0.03%
+11.5%
Q3 2018$7,015,000
-9.4%
461,4860.0%0.03%
-13.3%
Q2 2018$7,744,000
-18.1%
461,486
-20.4%
0.03%
-21.1%
Q1 2018$9,460,000
+99.4%
579,673
+56.4%
0.04%
+100.0%
Q4 2017$4,744,000
-14.6%
370,645
-17.9%
0.02%
-20.8%
Q3 2017$5,555,000
-15.9%
451,631
-42.8%
0.02%
-20.0%
Q2 2017$6,606,000
+12.7%
789,255
+20.4%
0.03%
+15.4%
Q1 2017$5,863,000
-24.2%
655,774
-25.5%
0.03%
-27.8%
Q4 2016$7,737,000
+32.7%
880,223
+1.9%
0.04%
+38.5%
Q3 2016$5,830,000
-2.8%
863,674
-48.8%
0.03%
-3.7%
Q2 2016$6,001,000
+15.9%
1,685,672
-3.9%
0.03%
+17.4%
Q1 2016$5,177,000
-31.2%
1,754,773
-1.6%
0.02%
-30.3%
Q4 2015$7,525,000
+83.3%
1,783,123
+98.0%
0.03%
+94.1%
Q3 2015$4,106,000
-38.1%
900,497
-2.1%
0.02%
-37.0%
Q2 2015$6,630,000
-2.2%
919,5470.0%0.03%
-3.6%
Q1 2015$6,777,000
+67.7%
919,547
+7.6%
0.03%
+75.0%
Q4 2014$4,042,000854,6060.02%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q2 2019
NameSharesValueWeighting ↓
Redmile Group, LLC 16,459,128$234,543,0009.43%
APIS CAPITAL ADVISORS, LLC 490,000$6,983,0009.36%
BVF INC/IL 4,744,062$67,603,0008.84%
First Light Asset Management, LLC 2,853,826$40,667,0006.48%
SECTORAL ASSET MANAGEMENT INC 2,165,767$30,862,0004.20%
GREAT POINT PARTNERS LLC 1,850,000$26,363,0003.33%
PACIFIC VIEW ASSET MANAGEMENT, LLC 146,952$2,092,0002.46%
Birchview Capital, LP 168,000$2,394,0002.26%
X-Square Capital, LLC 180,554$2,572,0002.02%
FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD 295,610$4,212,0001.54%
View complete list of ARRAY BIOPHARMA INC shareholders